Startups

Piur Imaging
Vienna, Austria · Munich, Germany · Cambridge, Massachusetts, United States
PIUR IMAGING develops vendor-agnostic AI-assisted tomographic 3D ultrasound software and sensor-based acquisition systems, including PIUR tUS Infinity and PIUR tUS inside. Its workflows reconstruct ultrasound volumes, assist thyroid and nodule segmentation and measurements, and support vascular imaging applications. Clinicians review the proposed results; company workflow/performance claims are not independent clinical validation. The current Austrian legal entity is PIUR IMAGING GmbH, Handelsgericht Wien FN442623t, VAT ATU70008412, with managing directors Frederik Bender and Robert Bauer. The published brand timeline starts in 2014, while older financing releases say founded2015; the official Austrian registry independently records the legal company entry on November19,2015, distinct from the brand timeline. Current operating offices are Vienna, Munich and Cambridge, Massachusetts; a separately named US subsidiary in the terms does not establish that every office is the same legal corporation. FDA records independently establish Infinity K240036 clearance on September20,2024 and inside K250484 clearance on June30,2025 for their specific stated indications, including adult22+ thyroid assessment; these are not blanket approvals of every vascular, neurological or autonomous-AI use. The inside press-page February2025 metadata predates the actual FDA decision and is not used as the clearance date. MDR/CE/ISO statements are qualified as own-company claims where independent certificates have not been audited. The current executive directory names three leaders, complemented here by separately dated primary technical, marketing, advisory and founder affiliations rather than an asserted complete private payroll. Financing history includes aws Seedfinancing support identified only by year2015, a 2017 H2020 grant with exact EUR674276.40 company contribution, the EUR4.9million SeriesA aggregate announcedJuly2023, EUR5.6million growth capital announcedJuly9,2025 led by ACP, and a Companisto-reported EUR2415900 SeriesB crowdfunding/SPV tranche closedJuly15,2026 from612 investors. The earlier2022 counsel announcement and March first-close manager history belong to the qualified SeriesA cycle; an extra company round or EUR2.13million incremental raise is not invented. The crowdfunding amount is the reported campaign tranche rather than a verified whole-SeriesB total, and its platform is not asserted to have invested that amount from its own balance sheet. Fractional grant money cannot be represented by the integer-only Money schema, so exact cents remain in the source and the monetary field is NULL. No aws loan draw or 2020 guaranteed bank credit is inferred without proof.
Founded 2014





